Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6287929

NCCC[C@@](N)(C(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CCCN)C(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@](N)(CCCN)C(=O)Cc3c[nH]c4ccccc34)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MC4R P32245 4/20 0.43
MC3R P41968 4/20 0.43
MC5R P33032 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
GOT1 P17174 2/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
PTBP1 P26599 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
USP2 O75604 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
GUSB P08236 1/20 0.38
FPR2 P25090 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6290842 0.97 MC3R (0.44) MC4RMC3RMC5RL3MBTL1GOT1
Hydrochloric Acid SCHEMBL6290971 0.91 MC4R (0.43) MC4RMC3RMC5RL3MBTL1MAPT
Hydrochloric Acid SCHEMBL6286771 0.91 MC4R (0.43) MC4RMC3RMC5RL3MBTL1MAPT
Trifluoroacetic Acid SCHEMBL6284180 0.87 MC3R (0.44) MC4RMC3RMC5RGOT1HRH3
SCHEMBL6286770 0.84 GOT1 (0.41) L3MBTL1GOT1MAPTSMN1; SMN2LMNA
SCHEMBL6288077 0.84 MAPK8 (0.42) L3MBTL1GOT1MAPTSMN1; SMN2LMNA
SCHEMBL6287689 0.83 L3MBTL1 (0.44) L3MBTL1GOT1MAPTSMN1; SMN2LMNA
SCHEMBL6287787 0.83 L3MBTL1 (0.44) L3MBTL1GOT1MAPTSMN1; SMN2LMNA
SCHEMBL6287427 0.83 MEN1 (0.47) L3MBTL1GOT1MAPTSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL6287926 0.82 MAPT (0.45) MC4RMC3RMC5RGOT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK MC4R 439/4885MC3R 335/4885MC5R 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.